Working… Menu

Long Term Safety of Alpha1-Proteinase Inhibitor in Subjects With Alpha1 Antitrypsin Deficiency (SPARTA-OLE)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02796937
Recruitment Status : Enrolling by invitation
First Posted : June 13, 2016
Last Update Posted : August 27, 2019
Information provided by (Responsible Party):
Grifols Therapeutics LLC

No Study Results Posted on for this Study
Recruitment Status : Enrolling by invitation
Estimated Primary Completion Date : December 2025
Estimated Study Completion Date : December 2025